Factor V Leiden - The commonest molecular defect in arterial and venous thrombophilia in India

Thrombosis Research

Volumn 110, Issue 1, 2003, Pages 19-21

  Ahmed, Rafeeq P H ^a   Gupta, Pawan K ^a   Kannan, M ^a   Choudhry, Ved Prakash ^a   Saxena, Renu ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Factor V Leiden; Methylene tetrahydrofolate reductase C677T; Prothrombin G20210A; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ALLELE; ARTERY THROMBOSIS; ARTICLE; BASAL GANGLION; BIOAVAILABILITY; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; HEREDITY; HETEROZYGOSITY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOPHILIA;

EID: 0012749942     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00101-4     Document Type: Article

References (13)

1. Seligsohn U., Zivelin A. Thrombophilia is a multigenic disorder. Thromb. Haemost. 78:1997;297-301.
2. De Stefano V., Finazzi G., Mannucci P.M. Inherited thrombophilia pathogenesis, clinical syndromes and management. Blood. 87:1996;3531-3544.
3. Dahlback B., Carlsson M., Svesson P.J. Familial thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a co factor to activated protein C. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1004-1008.
4. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H.et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
5. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkou NP, Boulyjenkov V, et-al. Inherited thrombophilia: Part 1 & 2. Thromb Haemost 1996;76:651-62 & 824-34.
6. Rees D.C., Cox M., Clegg J.B. World distribution of factor V Leiden. Lancet. 346:1995;1133-1134.
7. Zoller B., Svensson P.J., Hex Dahlback B. Identification of the same factor V gene mutation in 47 of 50 thrombosis - prone families with inherited resistance to activated protein C. J. Clin. Invest. 94:1994;2521-2524.
8. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi J.M., Costa F.F. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb. Haemost. 77(5):1997 (May);818-821.
9. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:1996;3698-3703.
10. Ghosh K., Shetty S., Madkaikar M., Pawar A., Nair S., Khare A.et al. Venous thromembolism in young patients from Western India: a study. Clin. Appl. Thromb./Hemost. 7(2):2001 (Apr);158-165.
11. Beauchamp N., Daly M., Hampton K., Cooper P., Preston F., Peake I. High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br. J. Haematol. 88:1994;219-222.
12. Frosst P., Blom H.J., Minlos R., Goyette P., Sheppard C.A., Malhewes R.G.et al. A candidate genetic risk factor for vascular disease; a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
13. Mohanty S., Saxena R., Behari M. APC resistance in young stroke patients. Thromb. Haemost. 81:1999;465-466.